Ftse Mib
35.355,87
0,58%
DAX
18.869,36
0,78%
S&P 500
5.308,15
1,17%
NASDAQ
16.742,39
1,40%
Bitcoin
65.869,16
7,02%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ambrx Biopharma Inc (AMAM) Ambrx Biopharma Inc (AMAM) Notizie

AMAM

Ambrx Biopharma (AMAM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMAM
DataOraFonteTitoloSimboloCompagnia
18/03/202419:45Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:AMAMAmbrx Biopharma Inc
12/03/202421:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMAMAmbrx Biopharma Inc
11/03/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AMAMAmbrx Biopharma Inc
08/03/202419:39Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMAMAmbrx Biopharma Inc
07/03/202419:23Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AMAMAmbrx Biopharma Inc
23/02/202420:09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMAMAmbrx Biopharma Inc
12/02/202419:43PR Newswire (US)Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law FirmNASDAQ:AMAMAmbrx Biopharma Inc
10/01/202421:07PR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:AMAMAmbrx Biopharma Inc
08/01/202420:54Dow Jones NewsTrending: Johnson & Johnson and Merck & Co. Announce AcquisitionsNASDAQ:AMAMAmbrx Biopharma Inc
08/01/202416:04Dow Jones NewsAmbrx Biopharma Shares Double on $2 Billion Acquisition by Johnson & JohnsonNASDAQ:AMAMAmbrx Biopharma Inc
08/01/202414:12Dow Jones NewsJohnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2 BillionNASDAQ:AMAMAmbrx Biopharma Inc
15/09/202322:27Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AMAMAmbrx Biopharma Inc
19/07/202315:49Dow Jones NewsAmbrx Biopharma Gets Fast Track Designation for ARX517 Cancer TreatmentNASDAQ:AMAMAmbrx Biopharma Inc
28/06/202322:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMAMAmbrx Biopharma Inc
28/06/202322:45Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AMAMAmbrx Biopharma Inc
28/06/202322:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMAMAmbrx Biopharma Inc
25/05/202322:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AMAMAmbrx Biopharma Inc
18/05/202322:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMAMAmbrx Biopharma Inc
16/05/202322:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AMAMAmbrx Biopharma Inc
11/05/202322:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMAMAmbrx Biopharma Inc
05/05/202322:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AMAMAmbrx Biopharma Inc
28/04/202322:22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:AMAMAmbrx Biopharma Inc
28/04/202322:09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMAMAmbrx Biopharma Inc
27/04/202322:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMAMAmbrx Biopharma Inc
18/04/202322:16Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AMAMAmbrx Biopharma Inc
03/04/202312:18Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:AMAMAmbrx Biopharma Inc
30/03/202323:23Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AMAMAmbrx Biopharma Inc
30/03/202322:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AMAMAmbrx Biopharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMAM

La tua Cronologia

BIT
UV8CSP
UniCredit Bank
LATK
CMKUSDT
Credmark
BOV
APTI3
ALIPERTI ON
COIN
SQRUSD
sQuorum
USOTC
PXFG
Phoenix Footwear (PK)
USOTC
SMCDF
Strategic Minerals (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network